Literature DB >> 18852943

[Liver transplantation: effects in pulmonary capacity, functional condition and quality of life].

Sílvia Barcelos1, Alexandre Simões Dias, Luiz Alberto Forgiarini, Mariane Borba Monteiro.   

Abstract

BACKGROUND: The liver transplantation is used for treatment of end-stage liver disease, where the survival and liver function are markedly improved after transplantation. AIM: To evaluate and compare lung function, functional capacity and quality of life in patients submitted to liver transplantation after 1, 3, 6, 9 and 12 months of procedure.
METHODS: Observational study with convenience groups composed by 30 patients, which had been divided in six groups (5 subjects each), in preoperative period and in the period of 1, 3, 6, 9 and 12 months after liver transplantation. All the individuals were evaluated at the same time, verificating the measurement of the forced vital capacity, forced expiratory volume in one second, maximum inspiratory and expiratory pressure, distance and domains related to quality of life.
RESULTS: According to the explanation, it was observed improvement in all variables in subsequent groups to the liver transplantation in periods of 1, 3, 6, 9 and 12 months when compared to the preoperative group. The most significant changes occurred during the maximum inspiratory pressures, the distance and physical functioning.
CONCLUSIONS: The liver transplantation as an alternative treatment for advanced liver disease, gives the patients benefits in respiratory and physical-functional conditions with improvement of life quality.

Entities:  

Mesh:

Year:  2008        PMID: 18852943     DOI: 10.1590/s0004-28032008000300003

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  1 in total

1.  The Perme scale score as a predictor of functional status and complications after discharge from the intensive care unit in patients undergoing liver transplantation.

Authors:  Camila Santos Pereira; Alexandra Torres de Carvalho; Adriane Dal Bosco; Luiz Alberto Forgiarini Júnior
Journal:  Rev Bras Ter Intensiva       Date:  2019 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.